logo-loader
ASX:1AD

AdAlta Ltd

Receive alerts
Market:
ASX
Price
0.0020 AUD
Day Change
-33.33%
Market Cap:
$6.42 m
52 weeks high
0.0080
52 weeks low
0.0020

In brief

AdAlta is a clinical stage biotechnology business addressing the need for effective cellular immunotherapies for the treatment of solid cancers.

The company's “East to West” cellular immunotherapy strategy is the primary driver of future growth and value creation initiatives.